EMR achieves similar oncological outcomes as ESD for gastric neoplasia of <1cm, requiring less expertise, training and time

Affiliations

¹ Division of Gastroenterology, University College London Hospitals, NHS Foundation Trust, London, UK matthew.banks2@nhs.net.
² Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.
³ Department of Gastroenterology, Queen Alexandra Hospital, Portsmouth, UK.
⁴ Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.

Comment

Matthew Banks et al. Gut. 2020 Sep.

. 2020 Sep;69(9):1.

doi: 10.1136/gutjnl-2019-319925. Epub 2019 Oct 5.

¹ Division of Gastroenterology, University College London Hospitals, NHS Foundation Trust, London, UK matthew.banks2@nhs.net.
² Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.
³ Department of Gastroenterology, Queen Alexandra Hospital, Portsmouth, UK.
⁴ Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.

No abstract available

Keywords: cancer; endoscopic procedures; endoscopy; gastric cancer.

Conflict of interest statement

Competing interests: None declared.

British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.
Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ, Rodriguez-Justo M, Novelli MR, Ragunath K, Shepherd N, Dinis-Ribeiro M. Banks M, et al. Gut. 2019 Sep;68(9):1545-1575. doi: 10.1136/gutjnl-2018-318126. Epub 2019 Jul 5. Gut. 2019. PMID: 31278206 Free PMC article.
ESD, not EMR, should be the first-line therapy for early gastric neoplasia.
Shahidi N, Bourke MJ. Shahidi N, et al. Gut. 2020 Sep;69(9):1-2. doi: 10.1136/gutjnl-2019-319646. Epub 2019 Sep 3. Gut. 2020. PMID: 31481547 No abstract available.